Docencia
Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study (23/06/2023)
Dr. Oskar Ayerdi Aguirrebengoa
Centro Sanitario Sandoval, IdISSC.
Hospital Clínico San Carlos, Madrid.
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial (09/06/2023)
Dra. Verónica Briz
Centro Nacional de Microbiología Instituto de Salud Carlos III.
Effects of clinical, comorbid, and social determinants of health on brain ageing in people with and without HIV: a retrospective case-control study (26/05/2023)
Dra. Isabel A. Pérez Hernández
Unidad de Enfermedades Infecciosas.
Hospital Universitario Virgen de la Victoria, Málaga.
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections (12/05/2023)
Dr. Boris Revollo B.
MD, PhD Germans Trias i Pujol University Hospital.
Infectious Diseases Department.
Fight Infections Foundation.
Early antirretroviral therapy not associated with higher cryptococcal meningitis mortality in people with HIV in high income countries : an international collaborative cohort study (28/04/2023)
Dra. Helena Albendín Iglesias
Hospital Clínico Universitario Virgen de la Arrixaca.
Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens (14/04/2023)
Dra. Miriam Estébanez Muñoz
Hospital Universitario “Gómez Ulla”, Madrid.
Sección Enfermedades Infecciosas, Medicina Interna.
Mpox in people with advanced HIV infection: a global case series (31/03/2023)
Dr. Oskar Ayerdi Aguirrebengoa
Centro Sanitario Sandoval, IdISSC.
Hospital Clínico San Carlos, Madrid.
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial (17/03/2023)
Dra. Verónica Briz
Centro Nacional de Microbiología Instituto de Salud Carlos III.
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departments (03/03/2023)
Dra. Isabel A. Pérez Hernández
Unidad de Enfermedades Infecciosas.
Hospital Universitario Virgen de la Victoria, Málaga.
Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort (17/02/2023)
Dr. Boris Revollo B.
MD, PhD Germans Trias i Pujol University Hospital.
Infectious Diseases Department.
Fight Infections Foundation.
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort (20/01/2023)
Dra. Miriam Estébanez Muñoz
Hospital Universitario “Gómez Ulla”, Madrid.
Sección Enfermedades Infecciosas, Medicina Interna.
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study (09/01/2023)
Dr. Oskar Ayerdi Aguirrebengoa
Centro Sanitario Sandoval, IdISSC.
Hospital Clínico San Carlos, Madrid.
Stable Latent HIV Infection and Low level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat (09/12/2022)
Dra. Verónica Briz
Centro Nacional de Microbiología.
Instituto de Salud Carlos III.
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention (25/11/2022)
Dra. Isabel A. Pérez Hernández
Unidad de Enfermedades Infecciosas
Hospital Universitario Virgen de la Victoria, Málaga.
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer (11/11/2022)
Dr. Boris Revollo
Germans Trias i Pujol University Hospital.
Infectious Diseases Department. Fight Infections Foundation.
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium (28/10/2022)
Helena Albendín Iglesias
Hospital Clínico Universitario Virgen de la Arrixaca.
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection (14/10/2022)
Dra. Miriam Estébanez Muñoz
Sección Enfermedades Infecciosas.
Medicina Interna Hospital Universitario “Gómez Ulla”, Madrid.
Two randomized trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition (17/06/2022)
Dra. Beatriz Mothe Pujadas
Servicio Enfermedades Infecciosas, IrsiCaixa
Hospital Germans Trias i Pujol, Badalona
Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis. Nathan Ford et al. Lancet HIV 2022; 9: e150–59 (03/06/2022)
Dr. Carlos Dueñas Gutiérrez
Hospital Clínico Universitario de Valladolid.
